Combining EGFR and mTOR blockade for the treatment of epithelioid sarcoma

PURPOSE: Molecular deregulations underlying epithelioid sarcoma (ES) progression are poorly understood yet critically needed to develop new therapies. EGFR is overexpressed in ES; using preclinical models, we examined the ES EGFR role and assessed anti-ES EGFR blockade effects, alone and with mTOR i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Xie, Xianbiao, Ghadimi, Markus PH, Young, Eric D., Belousov, Roman, Zhu, Quan-sheng, Liu, Juehui, Lopez, Gonzalo, Colombo, Chiara, Peng, Tingsheng, Reynoso, David, Hornick, Jason L, Lazar, Alexander J, Lev, Dina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3176924/
https://ncbi.nlm.nih.gov/pubmed/21821699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0660
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak